Yang Y M, Cepeda M, Price C, Shah A, Mankad V
Department of Pediatrics, University of South Alabama, College of Medicine, Mobile.
Arch Pediatr Adolesc Med. 1994 May;148(5):457-60. doi: 10.1001/archpedi.1994.02170050015003.
To look at the role of a standardized screening test for assessing depression in children and adolescents with and without sickle-cell disease and to compare findings with this instrument with clinical evaluations by child psychiatrists. In addition, to suggest the prevalence of clinical depression in children and adolescents with sickle-cell disease.
Nonrandomized, sequential sample of subjects, convenience control sample, prevalence study using the Children's Depression Rating Scale-Revised and an interview assessment by a child psychiatrist based on criteria from the Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition.
Comprehensive Sickle Cell Center outpatient clinic and ambulatory Resident Practice Clinic at the University of South Alabama Children's Medical Center, Mobile.
Patients aged 6 through 18 years with homozygous sickle-cell disease (hemoglobin SS) served as study subjects. Subjects of the same age and race who did not have sickle-cell disease served as controls.
The mean Children's Depression Rating Scale-Revised total scores were 27.1 and 22.1 in study and control groups, respectively (P = .0073). Eleven (29%) of 38 children in the study group had scores indicating a high risk for clinical depression. Four (12%) of 34 children in the control group were in this category. The four items accounting for most of this significant difference were excessive fatigue, physical complaints, self-esteem, and morbid ideation. This contrasted with the clinical evaluation by a child psychiatrist in a clinical interview in which 13% of study subjects and 15% of control subjects had evidence of clinical depression (P = .85).
Excessive fatigue and physical complaint factors contributed to a high false-positive rate when the Children's Depression Rating Scale-Revised was used to screen for depression among patients with sickle-cell disease. Based on the clinical interview by a child psychiatrist, the actual prevalence of clinical depression was not increased in children with sickle-cell disease compared with those without this chronic illness.
探讨标准化筛查测试在评估患和未患镰状细胞病的儿童及青少年抑郁症方面的作用,并将该工具的评估结果与儿童精神科医生的临床评估结果进行比较。此外,提出患镰状细胞病的儿童及青少年中临床抑郁症的患病率。
非随机、连续抽样的受试者、便利对照样本,采用儿童抑郁评定量表修订版进行患病率研究,并由儿童精神科医生根据《精神疾病诊断与统计手册》第三版修订本的标准进行访谈评估。
位于莫比尔的南阿拉巴马大学儿童医学中心综合镰状细胞中心门诊及门诊住院医师实习诊所。
6至18岁的纯合子镰状细胞病(血红蛋白SS)患者作为研究对象。同年龄、同种族且未患镰状细胞病的受试者作为对照。
研究组和对照组儿童抑郁评定量表修订版的平均总分分别为27.1和22.1(P = 0.0073)。研究组38名儿童中有11名(29%)得分表明有临床抑郁症的高风险。对照组34名儿童中有4名(12%)处于这一类别。造成这一显著差异的四个主要项目是过度疲劳、身体不适、自尊和病态想法。这与儿童精神科医生在临床访谈中的临床评估形成对比,在临床访谈中,13%的研究对象和15%的对照对象有临床抑郁症的证据(P = 0.85)。
当使用儿童抑郁评定量表修订版对镰状细胞病患者进行抑郁症筛查时,过度疲劳和身体不适因素导致了较高的假阳性率。根据儿童精神科医生的临床访谈,与未患这种慢性病的儿童相比,患镰状细胞病的儿童临床抑郁症的实际患病率并未增加。